{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:29:14Z","timestamp":1790008154128,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jval.2024.02.005","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T14:56:37Z","timestamp":1708613797000},"page":"830-836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Values Beyond \u201cHealth\u201d in Budget-Constrained Healthcare Systems"],"prefix":"10.1016","volume":"27","author":[{"given":"Charles E.","family":"Phelps","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jval.2024.02.005_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-6296(96)00506-1","article-title":"The economic foundations of cost-effectiveness analysis","volume":"16","author":"Garber","year":"1997","journal-title":"J\u00a0Health Econ"},{"key":"10.1016\/j.jval.2024.02.005_bib2","series-title":"Cost-Effectiveness in Health and Medicine","author":"Neumann","year":"2017"},{"issue":"5","key":"10.1016\/j.jval.2024.02.005_bib3","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0277-9536(02)00101-6","article-title":"Valuing the benefits and costs of health care programmes: where\u2019s the \u2018extra\u2019 in extra-welfarism?","volume":"589","author":"Birch","year":"2003","journal-title":"Soc Sci Med"},{"issue":"2","key":"10.1016\/j.jval.2024.02.005_bib4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jhealeco.2007.07.003","article-title":"Welfarism vs. extra-welfarism","volume":"27","author":"Brouwer","year":"2008","journal-title":"J\u00a0Health Econ"},{"issue":"5","key":"10.1016\/j.jval.2024.02.005_bib5","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.socscimed.2009.06.026","article-title":"Maximisation in extra-welfarism: a critique of the current position in health economics","volume":"69","author":"Coast","year":"2009","journal-title":"Soc Sci Med"},{"issue":"2","key":"10.1016\/j.jval.2024.02.005_bib6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jval.2017.12.006","article-title":"An overview of value, perspective and decision context\u2014a health economics approach: an ISPOR Special Task Force Report [2]","volume":"21","author":"Garrison","year":"2018","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.jval.2024.02.005_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jval.2017.12.007","article-title":"Defining elements of value in health care\u2014a health economics approach: an ISPOR special task force report","volume":"21","author":"Lakdawalla","year":"2018","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2024.02.005_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhealeco.2020.102346","article-title":"Health technology assessment with risk-aversion in health","volume":"72","author":"Lakdawalla","year":"2020","journal-title":"J\u00a0Health Econ"},{"issue":"2","key":"10.1016\/j.jval.2024.02.005_bib9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jval.2020.10.003","article-title":"Health technology assessment with diminishing returns to health: the Generalized Risk-Adjusted Cost-Effectiveness (GRACE) approach","volume":"24","author":"Lakdawalla","year":"2021","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.jval.2024.02.005_bib10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10198-021-01367-0","article-title":"A\u00a0guide to extending and implementing Generalized Risk-Adjusted Cost-Effectiveness (GRACE)","volume":"23","author":"Lakdawalla","year":"2022","journal-title":"Eur J Health Econ"},{"issue":"1","key":"10.1016\/j.jval.2024.02.005_bib11","first-page":"1","article-title":"The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) model for measuring the value of gains in health: an exact formulation","volume":"14","author":"Lakdawalla","year":"2023","journal-title":"J\u00a0Benefit Cost Anal"},{"key":"10.1016\/j.jval.2024.02.005_bib12","series-title":"Valuing Health: The Generalized Risk-Adjusted Cost Effectiveness (GRACE) Model","author":"Phelps","year":"2024"},{"issue":"7","key":"10.1016\/j.jval.2024.02.005_bib13","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jval.2023.02.001","article-title":"Methods to adjust willingness to pay (WTP) measures for severity of illness","volume":"26","author":"Phelps","year":"2023","journal-title":"Value Health"},{"issue":"299","key":"10.1016\/j.jval.2024.02.005_bib14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2307\/2228949","article-title":"A\u00a0theory of the allocation of time","volume":"75","author":"Becker","year":"1965","journal-title":"Econ J"},{"issue":"9","key":"10.1016\/j.jval.2024.02.005_bib15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s40273-023-01275-6","article-title":"Accounting for nonhealth and future costs in cost-effectiveness analysis: distributional impacts of a US cancer prevention strategy","volume":"41","author":"Kim","year":"2023","journal-title":"Pharmacoeconomics"},{"issue":"7 suppl 1","key":"10.1016\/j.jval.2024.02.005_bib16","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1097\/MLR.0b013e31819c9571","article-title":"Economic productivity by age and sex: 2007 estimates for the United States","volume":"47","author":"Grosse","year":"2009","journal-title":"Med Care"},{"key":"10.1016\/j.jval.2024.02.005_bib17","doi-asserted-by":"crossref","unstructured":"McGregor A, Caputi P. Measuring presenteeism. In: McGregor A, Caputi P, eds. Presenteeism Behaviour: Current Research, Theory and Future Directions. London, United Kingdom: Palgrave Macmillan:25-50.","DOI":"10.1007\/978-3-030-97266-0_2"},{"issue":"11 suppl","key":"10.1016\/j.jval.2024.02.005_bib18","first-page":"S265","article-title":"The option value of innovative treatments in the context of chronic myeloid leukemia","volume":"18","author":"Sanchez","year":"2012","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jval.2024.02.005_bib19","first-page":"1","article-title":"The option value of innovation","volume":"15","author":"Snider","year":"2012","journal-title":"Forum Health. Econ Policy"},{"issue":"11","key":"10.1016\/j.jval.2024.02.005_bib20","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.jval.2022.05.014","article-title":"A\u00a0pragmatic guide to assessing real option value for medical technologies","volume":"25","author":"Li","year":"2022","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2024.02.005_bib21","series-title":"Encyclopedia of Health Economics","first-page":"240","article-title":"Measuring health inequalities using the concentration index approach","author":"Kjellsson","year":"2014"},{"issue":"3","key":"10.1016\/j.jval.2024.02.005_bib22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0022-0531(70)90039-6","article-title":"On the measurement of inequality","volume":"2","author":"Atkinson","year":"1970","journal-title":"J\u00a0Econ Theor"},{"key":"10.1016\/j.jval.2024.02.005_bib23","series-title":"Prioritarianism in Practice","first-page":"37","article-title":"Theory of prioritarianism","author":"Adler","year":"2022"},{"key":"10.1016\/j.jval.2024.02.005_bib24","series-title":"Encyclopedia of Health Economics","first-page":"35","article-title":"Infectious disease externalities","author":"Gersovitz","year":"2014"},{"key":"10.1016\/j.jval.2024.02.005_bib25","series-title":"Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report","year":"2016"},{"key":"10.1016\/j.jval.2024.02.005_bib26","article-title":"Polio Health Economics: Assessing the Benefits and Costs of Polio, Non-polio, and Integrated Activities of the Global Polio Eradication Initiative. Version 1. Vol. 6","volume":"5","author":"Thompson","year":"2022","journal-title":"Gates Open Res"},{"key":"10.1016\/j.jval.2024.02.005_bib27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpubeco.2016.11.012","article-title":"The insurance value of medical innovation","volume":"145","author":"Lakdawalla","year":"2017","journal-title":"J\u00a0Public Econ"},{"issue":"2","key":"10.1016\/j.jval.2024.02.005_bib28","first-page":"675","article-title":"Environmental economics: a survey","volume":"30","author":"Cropper","year":"1992","journal-title":"J\u00a0Econ Lit"},{"issue":"94","key":"10.1016\/j.jval.2024.02.005_bib29","first-page":"19","article-title":"Valuing the environment through contingent valuation","volume":"8","author":"Michael","year":"1994","journal-title":"J\u00a0Econ Perspect"},{"issue":"5259","key":"10.1016\/j.jval.2024.02.005_bib30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1126\/science.272.5259.221","article-title":"Is there a role for benefit-cost analysis in environmental, health and safety regulation?","volume":"272","author":"Arrow","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jval.2024.02.005_bib31","series-title":"The Measurement of Environmental and Resource Values: Theory and Methods","author":"Freeman","year":"2003"},{"issue":"4","key":"10.1016\/j.jval.2024.02.005_bib32","first-page":"53","article-title":"Valuing the environment for decision-making","volume":"28","author":"Binder","year":"2012","journal-title":"Issues Sci Technol"},{"issue":"3","key":"10.1016\/j.jval.2024.02.005_bib33","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1006\/obhd.1994.1087","article-title":"SMARTS and SMARTER: improved simple methods for multi-attribute utility measurement","volume":"60","author":"Edwards","year":"1994","journal-title":"Behav Hum Decis Processes"},{"issue":"1","key":"10.1016\/j.jval.2024.02.005_bib34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10479-007-0183-3","article-title":"Transparent prioritization, budgeting and resource allocation with multi-criteria decision analysis and decision conferencing","volume":"154","author":"Phillips","year":"2007","journal-title":"Ann Oper Res"},{"issue":"5","key":"10.1016\/j.jval.2024.02.005_bib35","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jval.2022.11.007","article-title":"The use of multicriteria decision analysis to support decision making in healthcare: an updated systematic literature review","volume":"26","author":"Gongora-Salazar","year":"2023","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2024.02.005_bib36","series-title":"Multi-criteria Decision Analysis to Support Healthcare Decisions","first-page":"329","author":"Marsh","year":"2017"},{"issue":"4","key":"10.1016\/j.jval.2024.02.005_bib37","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jval.2017.10.001","article-title":"The Use of MCDA in HTA: great potential but more effort is needed","volume":"21","author":"Marsh","year":"2018","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.jval.2024.02.005_bib38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jval.2015.12.016","article-title":"Multiple criteria decision analysis for health care decision making\u2014emerging good practices: report 2 of the ISPOR MCDA Emerging Good Practices Task Force","volume":"19","author":"Marsh","year":"2016","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.jval.2024.02.005_bib39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jval.2016.11.011","article-title":"Using multicriteria approaches to assess","volume":"20","author":"Phelps","year":"2017","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2024.02.005_bib40","series-title":"Making Better Choices: Design, Decisions and Democracy","author":"Phelps","year":"2021"},{"issue":"9","key":"10.1016\/j.jval.2024.02.005_bib42","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2165\/00019053-200826090-00004","article-title":"The NICE cost-effectiveness threshold: what it is and what it means","volume":"26","author":"McCabe","year":"2008","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"10.1016\/j.jval.2024.02.005_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19140","article-title":"Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold","volume":"19","author":"Claxton","year":"2015","journal-title":"Health Technol Assess"},{"issue":"7","key":"10.1016\/j.jval.2024.02.005_bib45","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jval.2019.03.003","article-title":"A\u00a0new method for determining the optimal willingness to pay in cost-effectiveness analysis","volume":"22","author":"Phelps","year":"2019","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.jval.2024.02.005_bib46","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/hec.4268","article-title":"Estimating optimal willingness to pay thresholds for cost-effectiveness analysis: a generalized method","volume":"30","author":"Phelps","year":"2021","journal-title":"Health Econ"},{"issue":"15","key":"10.1016\/j.jval.2024.02.005_bib47","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/jama.2023.1792","article-title":"Cost-effectiveness thresholds used by study authors, 1990-2021","volume":"329","author":"Neumann","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jval.2024.02.005_bib48","series-title":"Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis","author":"Tan-Torres Edjerer","year":"2003"},{"issue":"11","key":"10.1016\/j.jval.2024.02.005_bib50","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jval.2023.08.001","article-title":"On the (near) equivalence of welfarist economic and extra-welfarist methods to value healthcare and implications for social welfare functions and equity","volume":"26","author":"Phelps","year":"2023","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.jval.2024.02.005_bib51","first-page":"309","article-title":"Cardinal welfare, individualistic ethics, and interpersonal comparisons of utility","volume":"63","author":"Harsanyi","year":"1955","journal-title":"J\u00a0Pol Econ"},{"issue":"2","key":"10.1016\/j.jval.2024.02.005_bib52","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1099-1050(199703)6:2<117::AID-HEC256>3.0.CO;2-B","article-title":"Intergenerational equity: an exploration of the \u2018fair innings\u2019 argument,\u201d","volume":"6","author":"Williams","year":"1998","journal-title":"Health Econ"}],"updated-by":[{"DOI":"10.1016\/j.jval.2025.12.006","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000}},{"DOI":"10.1016\/j.jval.2025.12.006","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301524000755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301524000755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:05:50Z","timestamp":1751357150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301524000755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1098301524000755"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2024.02.005","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Values Beyond \u201cHealth\u201d in Budget-Constrained Healthcare Systems","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2024.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}